Tissue inhibitor of metalloproteinase proteins inhibit teratoma growth in mice transplanted with pluripotent stem cells
Authors:
- 28 November 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 38 (4) , 516-529
Abstract
Pluripotent stem cells (PSCs) can serve as an unlimited cell source for transplantation therapies for treating various devastating diseases, such as cardiovascular diseases, diabetes, and Parkinson's disease. However, PSC transplantation has some associated risks, including teratoma formation from the remaining undifferentiated PSCs. Thus, for successful clinical application, it is essential to ablate the proliferative PSCs before or after transplantation. In this study, neural stem cell‐derived conditioned medium (NSC‐CM) inhibited the proliferation of PSCs and PSC‐derived neural precursor (NP) cells without influencing the potential of PSC‐NP cells to differentiate into neurons in vitro and prevented teratoma growth in vivo. Moreover, we found that the NSC‐CM remarkably decreased the expression levels of Oct4 and cyclin D1 that Oct4 directly binds to, and increased the cleaved‐caspase 3‐positive cell death through the DNA damage response in PSCs and PSC‐NPs. Interestingly, we found that NSCs distinctly secreted the tissue inhibitor of metalloproteinase (TIMP)‐1 and TIMP‐2 proteins. These protein suppressed not only the proliferation of PSCs in cell culture but also teratoma growth in mice transplanted with PSCs through inhibition of matrix metalloproteinase (MMP)‐2 and MMP‐9 activity. Taken together, these results suggest that the TIMP proteins may improve the efficacy and safety of the PSC‐based transplantation therapy. © AlphaMed Press 2019 Significance Statement It is essential to ablate the proliferative pluripotent stem cells (PSCs) before or after transplantation for the clinical applications due to some associated risks, including teratoma formation from remaining undifferentiated PSCs. In this study, neural stem cell‐conditioned medium (NSC‐CM) and/or TIMP proteins prevented teratoma growth in vivo.Keywords
Funding Information
- Ministry of Science and ICT (2019M3E5D5065399)
- Ministry of Health & Welfare (HR14C0007)
- Ministry of Science and ICT (2019M3E5D5065399)
- Ministry of Health & Welfare (HR14C0007)
This publication has 63 references indexed in Scilit:
- Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem CellsMolecular Cell, 2012
- An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cellsNature Biotechnology, 2011
- Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small moleculesCell Research, 2010
- Oct-4 controls cell-cycle progression of embryonic stem cellsBiochemical Journal, 2010
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Functional Analysis of Various Promoters in Lentiviral Vectors at Different Stages of In Vitro Differentiation of Mouse Embryonic Stem CellsMolecular Therapy, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastropheCell Death & Differentiation, 2002
- A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryoNature, 1990
- New type of POU domain in germ line-specific protein Oct-4Nature, 1990